Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma - Fink, Wolfram; Figl, Adina; Figl, Robert; Ugurel, Selma; Schadendorf, Dirk (Onkologie, 2004)
Gesehen am 11.12.2020